2022 Annual Meeting | S38 - All Things HIV and ID

Date Thursday 04/07/22

Time 03:30 PM - 05:30 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Scientific Platform Session

Moderator(s) Felicia Chow, MD, Christina Marra, MD, FAAN

Topic(s) Infectious Disease

CME Available 2.00 CME credits

Program Materials Program Evaluations

Event Timeline
03:30 PM - 03:42 PM PDT	Speaker	2022 AAN Neuro-infectious Disease Award: This award recognizes individuals who have made a contribution to neuro-infectious disease research. Payal B. Patel, MD
03:30 PM - 03:30 PM PDT	Speaker	Walk-in Slides Payal B. Patel, MD
03:42 PM - 03:54 PM PDT	Abstract	002 - Evolving Clinical and Epidemiological Patterns of CNS Infections in People with HIV Over 25 Years Miranda Wan, MD
03:54 PM - 04:06 PM PDT	Abstract	003 - Decreased Myelin Content and Associated Cognitive Performance in Adults Living with Perinatally-Acquired HIV Payal B. Patel, MD
04:06 PM - 04:18 PM PDT	Abstract	004 - Unique Brain-Specific Antibody Signatures in Chronic HIV Infection Marianna Spatola, MD, PhD
04:18 PM - 04:30 PM PDT	Abstract	005 - Circadian trends in CSF Amyloid beta-42 levels in HIV Visesha Kakarla
04:30 PM - 04:42 PM PDT	Abstract	006 - Time to Confirmed Neuro-infection Diagnoses: Characterization of Current Trends and Implications for Diagnostic Testing Approaches Abhilasha P. Boruah
04:42 PM - 04:54 PM PDT	Abstract	007 - Infectious Causes of Chronic Meningitis in Neurosurgical Patients Tyler Crissinger, MD
04:54 PM - 05:06 PM PDT	Abstract	008 - Acute seizure risk in encephalitis; analysis and modelling of 436 patients from two independent multi-centre cohorts Greta K. Wood, MBBS
05:06 PM - 05:18 PM PDT	Abstract	009 - Utility and Feasibility of Portable Ultra-Low Field MRI in Patients with Progressive Multifocal Leukoencephalopathy Karan D. Kawatra, Other
05:18 PM - 05:30 PM PDT	Abstract	010 - Diagnostic Value of Clinical Phenotype and Clinical Tests in Early Creutzfeldt-Jakob Disease Dror Shir, MD

Faculty Disclosures
Shila Azodi, MD	Dr. Azodi has nothing to disclose.
	No disclosure on file
Amanda L. Porter, MD	Dr. Porter has nothing to disclose.
Christos J. Petropoulos, PhD	Dr. Petropoulos has received personal compensation for serving as an employee of Monogram Biosciences-Labcorp. Dr. Petropoulos has received stock or an ownership interest from Laboratory Corporation of America Holdings. Dr. Petropoulos has received intellectual property interests from a discovery or technology relating to health care.
Mark A. Ellul, MD	No disclosure on file
Joseph Seemiller, MD	Dr. Seemiller has nothing to disclose.
J. David Avila, MD	Dr. Avila has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alnylam Pharmaceuticals. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for argenx. Dr. Avila has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda.
Dana H. Gabuzda, MD	Dr. Gabuzda has nothing to disclose.
Vijay K. Ramanan, MD, PhD	The institution of Dr. Ramanan has received research support from the National Institutes of Health. The institution of Dr. Ramanan has received research support from the Mangurian Foundation for Lewy Body Disease Research. The institution of Dr. Ramanan has received research support from as part of clinical trials sponsored by the Alzheimer's Association, Eisai, the Alzheimer's Treatment and Research Institute at USC, and Transposon Therapeutics, Inc.. The institution of Dr. Ramanan has received research support from Medscape. Dr. Ramanan has received personal compensation in the range of $500-$4,999 for serving as a Conference Speaker/Organizer (Honoraria) with AANI.
Dror Shir, MD	Dr. Shir has nothing to disclose.
Govind Nair	No disclosure on file
Tom Solomon, MD	No disclosure on file
David T. Jones, MD	Dr. Jones has received intellectual property interests from a discovery or technology relating to health care.
Kiran Thakur, MD, FAAN	The institution of Dr. Thakur has received research support from Center for Disease Control and Prevention.
Gregory S. Day, MD, MSc, FAAN	Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Parabon Nanolabs. The institution of Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from Chan Zuckerberg Initiative. The institution of Dr. Day has received research support from Alzheimer's Association. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Horizon Therapeutics. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with American Academy of Neurology. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing Education, Inc. Dr. Day has a non-compensated relationship as a Clinical Director with AntiNMDA Receptor Encephalitis Foundation that is relevant to AAN interests or activities.
Erin Sundermann	The institution of Erin Sundermann has received research support from California Department of Public Health.
Marianna Spatola, MD, PhD	The institution of Dr. Spatola has received research support from Spanish National Health Institute (Carlos III). The institution of Dr. Spatola has received research support from Spanish National Institute of Health - Miguel Servet Grant.
Evelyn Lazar, MD	Dr. Lazar has nothing to disclose.
Allen J. Aksamit, Jr., MD, FAAN	Dr. Aksamit has nothing to disclose.
Payal B. Patel, MD	The institution of Dr. Patel has received research support from National Institute of Health. The institution of Dr. Patel has received research support from AHRQ. Dr. Patel has received personal compensation in the range of $0-$499 for serving as a Author with MedLink Neurology.
Scott L. Letendre, MD	The institution of Dr. Letendre has received research support from National Institutes of Health. The institution of Dr. Letendre has received research support from University at Buffalo. Dr. Letendre has received publishing royalties from a publication relating to health care.
John Winslow, PhD	Dr. Winslow has received personal compensation for serving as an employee of Monogram Biosciences/Labcorp. Dr. Winslow has stock in Labcorp. Dr. Winslow has received intellectual property interests from a discovery or technology relating to health care.
Ahmed Chenna, PhD	Dr. Chenna has received personal compensation for serving as an employee of LabCorp-monogram Biosciences.
Christina Marra, MD, FAAN	Dr. Marra has received publishing royalties from a publication relating to health care. Dr. Marra has received personal compensation in the range of $0-$499 for serving as a grant reviewer with NIH.
Shibani S. Mukerji, MD, PhD	Dr. Mukerji has stock in Gilead Science. The institution of Dr. Mukerji has received research support from NIH. The institution of Dr. Mukerji has received research support from Massachusetts General Hospital.
Daniel Reich, MD, PhD	Dr. Reich has received research support from NIH. The institution of Dr. Reich has received research support from Adelson Medical Research Foundation. The institution of Dr. Reich has received research support from Sanofi-Genzyme. The institution of Dr. Reich has received research support from Abata Therapeutics. The institution of Dr. Reich has received research support from National Multiple Sclerosis Society. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with PeerView. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with AcademicCME. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Integrity. Dr. Reich has a non-compensated relationship as a Advisor with Sanofi-Genzyme that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Board of Directors with ACTRIMS that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Abata Therapeutics that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with American Brain Foundation that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with University of Basel RC2NB that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Multiple Sclerosis Society of Canada that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Tuscan Doctorate in Neuroscience that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Editorial Board with Multiple Sclerosis Journal that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Biohaven that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Sana that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Merck KGaA EMD Serono that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Bristol-Meyers Squibb that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with ChemoCentryx that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Hyperfine that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Imaginab that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Perceptive that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Annexon that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Philips that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Siemens that is relevant to AAN interests or activities.
John Herbst, DO	Dr. Herbst has nothing to disclose.
Kelly Baldwin, MD	Dr. Baldwin has nothing to disclose.
Ava M. Easton, PhD	Dr. Easton has received personal compensation for serving as an employee of Encephalitis Society. Dr. Easton has received publishing royalties from a publication relating to health care.
Galit Alter	No disclosure on file
Visesha Kakarla	Miss Kakarla has nothing to disclose.
Tyler Crissinger, MD	Dr. Crissinger has nothing to disclose.
Greta K. Wood, MBBS	Dr. Wood has nothing to disclose.
Serena Spudich, MD	The institution of Dr. Spudich has received research support from NIH.
Rachelle Dugue, MD, PhD	Dr. Dugue has nothing to disclose.
Hugo Botha, MD	Dr. Botha has received research support from NIH.
Carla Kim	No disclosure on file
Karan D. Kawatra, Other	Mr. Kawatra has nothing to disclose.
Anita M. Fletcher, MD	Dr. Fletcher has nothing to disclose.
Jennifer Chiarella	No disclosure on file
Miranda Wan, MD	Dr. Wan has nothing to disclose.
Jonathan Graff-Radford, MD, FAAN	Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Cognition therapeutics.
Angela Vincent, MBBS, MSc	Angela Vincent, MBBS,MSc has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Angela Vincent, MBBS,MSc has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Angela Vincent, MBBS,MSc has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Angela Vincent, MBBS,MSc has received intellectual property interests from a discovery or technology relating to health care. Angela Vincent, MBBS,MSc has received intellectual property interests from a discovery or technology relating to health care.
Abhilasha P. Boruah	Ms. Boruah has nothing to disclose.
Yair Mina, MD	Dr. Mina has nothing to disclose.
Christian C. Prusinski, DO	Dr. Prusinski has nothing to disclose.
Jeremy K. Cutsforth-Gregory, MD, FAAN	Dr. Cutsforth-Gregory has received publishing royalties from a publication relating to health care.
Irene Cortese, MD	Dr. Cortese has stock in Keires, AG. Dr. Cortese has stock in Nouscom, AG. Dr. Cortese has stock in PDC Pharma. Dr. Cortese has a non-compensated relationship as a scientific advisor with Cellevolve that is relevant to AAN interests or activities.
Eileen Harrigan, MD	Dr. Harrigan has nothing to disclose.
Shannon Kolind, PhD, MSc, BSc	Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Kolind has received research support from Sanofi Genzyme. The institution of Dr. Kolind has received research support from Roche. The institution of Dr. Kolind has received research support from Biogen.
Ronald J. Ellis, MD, PhD, FAAN	Dr. Ellis has nothing to disclose.
Christopher Power, MD	Dr. Power has nothing to disclose.
Felicia Chow, MD	Dr. Chow has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Medicolegal consulting. The institution of Dr. Chow has received research support from NIH.